Last reviewed · How we verify

POLYGYNAX® — Competitive Intelligence Brief

POLYGYNAX® (POLYGYNAX®) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combination antibiotic and antifungal agent. Area: Infectious Disease / Gynecology.

phase 3 Combination antibiotic and antifungal agent Infectious Disease / Gynecology Small molecule Live · refreshed every 30 min

Target snapshot

POLYGYNAX® (POLYGYNAX®) — Laboratoire Innotech International. POLYGYNAX is a vaginal capsule containing a combination of antibiotics and antifungal agents that eliminates pathogenic bacteria and fungi in the vaginal tract.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
POLYGYNAX® TARGET POLYGYNAX® Laboratoire Innotech International phase 3 Combination antibiotic and antifungal agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combination antibiotic and antifungal agent class)

  1. Laboratoire Innotech International · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). POLYGYNAX® — Competitive Intelligence Brief. https://druglandscape.com/ci/polygynax. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: